動物用薬剤(コンパニオンアニマル、寄生虫駆除剤、ワクチン、その他)の世界市場

◆英語タイトル:Animal Medication (Companion Animals, Parasiticides, Vaccines, etc.) : Global Strategic Business Report
◆商品コード:GIA60053
◆発行会社(調査会社):Global Industry Analysts
◆発行日:2016年4月
◆ページ数:387
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Single User(DRM付き)USD4,950 ⇒換算¥564,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobal Industry Analysts社の日本における正規販売代理店です。Global Industry Analysts社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、動物用薬剤(コンパニオンアニマル、寄生虫駆除剤、ワクチン、その他)の世界市場について調査・分析し、動物用薬剤(コンパニオンアニマル、寄生虫駆除剤、ワクチン、その他)の世界市場規模、市場動向、市場予測、関連企業情報などをお届けいたします。
【レポートの概要】

This report analyzes the worldwide markets for Animal Medication in US$ Million by the following End-Use Segments: Companion Animals, and Farm Animals. The Global market is further analyzed by the following Product Groups: Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 113 companies including many key and niche players such as –
Bayer HealthCare AG
Boehringer Ingelheim GmbH
Ceva Santé Animale S.A
Dechra Pharmaceuticals PLC
Eli Lilly and Company

【レポートの目次】

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
II. EXECUTIVE SUMMARY
1. MARKET OUTLOOK
Growing Demand for Animal Protein and Rising Pet Ownership Drives Animal Medication Market
Developed Regions Ahead; Developing Markets Gathering Momentum
Farm Animals – The Largest Market Category
Parasiticides Stay in the Lead; Vaccines Drive Growth
Importance of Animal Health: A Prelude
2. MARKET TRENDS & DYNAMICS
Growing Pet Ownership and Spending Drives Demand
Table 1: World Pet Dog Ownership (2016E): Top Ten Nations with Dog Population in Millions (includes corresponding Graph/Chart)
Table 2: World Pet Cat Ownership (2016E): Top Ten Nations with Cat Population in Millions (includes corresponding Graph/Chart)
Companion Animals: A High Value Lucrative Market Segment
Need to Reduce the Foot Print of Food Production Drives Gains
Spread of Zoonotic Diseases Propels Growth
Unmet Animal Health Needs Drives Growth
Need to Ensure Sustainable Food Supply Spurs Growth
Increasing Demand for Animal Protein in Developing Countries to Benefit the Market
Opportunity Indicators
Table 3: Projected Global Per Capita Consumption of Meat (in kg per year) by Geographic Region by the year 2030 (includes corresponding Graph/Chart)
Table 4: Projected Global Consumption of Animal Products (in million tons) by Developing and Developed Countries for the year 2030 (includes corresponding Graph/Chart)
Flavored Veterinary Medications Registers Notable Growth
Safety Concerns: An Opportunity Generator
Healthy Investments in Veterinary Pharmaceuticals Drive Growth
Role of Pharmacokinetics in Animal Drug Development
Animal Health Market Expected to Gain from Antimicrobial Resistance
Responsible use of Animal Medicines Ignites Interest in Herbal Alternatives
Will the Growing Support for Hormone and Antibiotic Free Animal Produce Impact the Growth Prospects of the Animal Medicine?
Growing Momentum for Post Slaughter Strategies Bodes well for Animal Medicine
Demand for Metabolic Modifiers Surging
Genomics to Influence Development of Animal Medicine in the Future
Nanotechnology Fast Gaining Ground in Animal Medicine
Animal Drug Distribution and Dispensing Sees Transformation – A Growing Threat to Veterinarians
Generic Insurgency in Animal Health Market – Not As Strong As in Human Health
Human Drugs Continue to Permeate Animal Drug Market, Manufacturers Queue in to Capitalize on Growing Prospects
Managing a Portfolio of Drugs – Key to Business Risk Aversion
Aquaculture Medicines – A Growing Niche in the Animal Medication Market
3. VETERINARY VACCINES MARKET – AN OVERVIEW
Veterinary Vaccine Market on a High Growth Track
Table 5: World Veterinary Vaccines Market (2014): Percentage Breakdown of Dollar Sales of Vaccines by Product Segment – Companion (Canine, Feline) and Livestock (Porcine, Bovine, Poultry, Ovine, Equine and other Animal Vaccines) (includes corresponding Graph/Chart)
Veterinary Vaccines Market – Demographic Differences and Market Challenges
Recombinant DNA Technology Boosts the Animal Vaccine Industry
Pricing Affects Livestock Medication Market
The Need for Innovative Vaccine Delivery Mechanism Increasing
Egg-Derived Veterinary Vaccines in Human Vaccine Facilities
Will Plant-Derived Vaccines Hold Potential in Animal Health Care Industry?
More Vaccines Needed to Prevent Zoonotic Infections
Parasitic Vaccines Segment Holds Potential
Marker Vaccines Playing a Vital Role in Disease Detection
4. COMPETITIVE LANDSCAPE
Zoetis – The Animal Medication Leader
Table 6: Leading Players in the Global Animal Medication Market (2014 & 2015): Annual Sales of Animal Health Products in US$ Million for Bayer, Boehringer Ingelheim, Eli Lilly/Elanco, Merck & Co. / MSD Santé Animale, Merial and Zoetis (includes corresponding Graph/Chart)
Apoquel – A New Blockbuster Drug Strengthening Zoetis’ Dermatology Portfolio
Market Ripe for Consolidation
Boehringer Ingelheim Eyes Business Expansion
Table 7: Boehringer Ingelheim’ Leading Animal Medication Drugs (2014): Annual Sales in US$ Million for Duramune, Ingelvac Circoflex, Ingelvac PRRS, Metacam and Vetmedin (includes corresponding Graph/Chart)
Acquisition of Novartis’ Animal Health Business Bolsters Elanco’s Market Presence
New Products Drive Growth in Bayer’s Animal Health Segment
5. PRODUCT OVERVIEW
Animal Medication: An Introduction
Preventive Medicines
Therapeutic Medicines
Others
Considerations
Need for Medications in Companion Animals
Commonly Prescribed (Rx) Animal Health Medications
Non-Prescription Medications
Types of Non-Prescription Medications
Types of Animal Medication
Pharmaceuticals
Medicinal Feed Additives
Biologicals (excluding Vaccines)
Veterinary Vaccines
Classification of Veterinary Vaccines
Companion Animals Vaccines
Canine Vaccines
Feline Vaccines
Livestock Vaccines
A Tabular Analysis on Select Animal Diseases Controlled by Vaccines
6. PRODUCT LAUNCHES/APPROVALS
Dechra Veterinary Products to Launch Zycortal in the UK
Zoetis Obtains Conditional License from USDA for Avian Influenza Vaccine
Zoetis Rolls Out CLARIFIDE® Plus Genomic Test for Holstein Cattle
Zoetis Obtains FDA Approval for Simparica™
Merck Animal Health Introduces Safe-Guard® AquaSol for Ascaridia galli Treatment in Chicken
Bionaturis Introduces Five New Developmental Stage Animal Health Biotech Products
Merck Animal Health Obtains EC Approval for PORCILIS® PCV ID Vaccine
Bayer Obtains Approval for Claro™ for Treating Otitis Externa in Canines
Boehringer Ingelheim Rolls Out New Swine Vaccines for PRRS in Europe
Merial Launches Tablet Vaccine for NDV Prevention
Bayer Introduces Immunostimulant Zelnate® for Reducing Bovine Respiratory Disease
Merck Animal Health Launches INNOVAX®-ILT in EU
Merck Animal Health Rolls Out FORTEGRA® Vaccine in Latin America
Elanco Launches Canine Otitis Externa Treatment Medication – Osurnia®
Ceva Animal Health Rolls Out Canine Heart Failure Management Medication – Libeo
Dechra Veterinary Products Rolls Out 5 ml Bottle Dosage of Comfortan®
Merck Animal Health Launches AQUAVAC® PD3 Vaccine for Salmon
Innovacyn Launches Improved Vetericyn® Plus Medications for Beef Cattle and Dairy
Merck Animal Health Rolls Out PORCILIS® PCV M Hyo in Europe
Boehringer Ingelheim Obtains EU Marketing Approval for Bovela®
Ceva Announces US Availability of Tildren®
Zoetis Relaunches Zoamix® Synthetic Anticoccidial
Merck Animal Health Obtains EC Approval of PORCILIS® PCV M Hyo
Merck Animal Health Launches FINADYNE® Transdermal Solution for Reducing Pyrexia and BRD
Merck Animal Health Obtains EC Marketing Authorization for NOBILIS® IB Primo QX
Merck Animal Health Launches New Fish Vaccine in Asia
Merial Announces Global Launch of PUREVAX® Feline Rabies 3 YR Vaccine
Novartis Rolls Out Florvio for Treating SRD at World Pork Expo
Boehringer Ingelheim Canada Launches Semintra® for Treating Chronic Kidney Disease in Cats
Boehringer Ingelheim Rolls Out Cat Vaccine Line – ULTRA™ Fel-O-Vax®
Innovacyn Introduces 4-Ounce Feline Hydrogel
Novartis Launches Strenzen®
Eco Animal Health’s Aivlosin Receives Marketing Approval
7. RECENT INDUSTRY ACTIVITY
Harrisvaccine’ RNA Particle Vaccine Platform Obtains USDA Licensure
Ceva Acquires India-based Polchem
Merial and Zoetis Ink Marketing and Distribution Agreement for Dairy Vaccines and Medicines in India
Huvepharma Acquires Zoetis’ Longmont Facility
Zydus Cadila Acquires Select Assets of Zoetis in India
Sanofi and Boehringer Ingelheim Ink Business Swap Agreement
Merck Animal Health Receives Conditional License for New Canine Influenza Vaccine
Merck Animal Health to Acquire Harrisvaccines
Zoetis Takes Over PHARMAQ
Merck Animal Health Announces New Indication for FINADYNE® Transdermal Solution
Zoetis Receives Conditional License from USDA for Canine Atopic Dermatitis Immunotherapeutic
Zoetis Obtains Registration for Equivac® HeV from APVMA
Zoetis Completes Expansion at Lincoln, Nebraska-based Facility
Merck Animal Health and China Animal Husbandry Industry ink MoU
Merck Animal Health Registers Two Vaccines in Vietnam
Merial Acquires Equine Products LEGEND® and MARQUIS® from Bayer
Zoetis Acquires Abbott’s Animal Health Assets
Dechra Renames Fucithalmic® Vet Eye Medicines as Isathal®
Virbac and Nexvet Ink Development and Marketing Collaboration Agreement for mAb-based Animal Medications
Bayer and DNDi ink Agreement for Developing New Oral Medication to Treat Onchocerciasis
Merial Expands Paulinia Plant Capacity NEXGARD® Production
Novartis Spins Off Animal Health Business
Elanco to Take Over Lohmann Animal Health
Zoetis Reports Shortage of Apoquel Drug
Vétoquinol Acquires Bioniche
8. FOCUS ON SELECT GLOBAL PLAYERS
Bayer HealthCare AG (Germany)
Boehringer Ingelheim GmbH (Germany)
Ceva Santé Animale S.A. (France)
Dechra Pharmaceuticals PLC (UK)
Eli Lilly and Company (USA)
Merck Animal Health (Netherlands)
Merial (France)
Vetericyn, Inc. (USA)
Vétoquinol SA (France)
Virbac SA (France)
Zoetis, Inc. (USA)
9. GLOBAL MARKET PERSPECTIVE
Table 8: World Recent Past, Current and Future Analysis for Animal Medication Products by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 9: World Historic Review for Animal Medication Products by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 10: World 14-Year Perspective for Animal Medication Products by Geographic Region/Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
Table 11: World Recent Past, Current and Future Analysis for Companion Animal Medication Products by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 12: World Historic Review for Companion Animal Medication Products by Geographic Region/ Country – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 13: World 14-Year Perspective for Companion Animal Medication Products by Geographic Region/ Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
Table 14: World Recent Past, Current and Future Analysis for Farm Animal Medication Products by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 15: World Historic Review for Farm Animal Medication Products by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 16: World 14-Year Perspective for Farm Animal Medication Products by Geographic Region/Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
Table 17: World Recent Past, Current and Future Analysis for Animal Medication Products by Farm Animal Type – Cattle, Pigs, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 18: World Historic Review for Animal Medication Products by Farm Animal Type – Cattle, Pigs, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 19: World 14-Year Perspective for Animal Medication Products by Farm Animal Type – Percentage Breakdown of Dollar Sales for Cattle, Pigs, and Others Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
Table 20: World Recent Past, Current and Future Analysis of Animal Medication Products for Cattle by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 21: World Historic Review of Animal Medication Products for Cattle by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 22: World 14-Year Perspective of Animal Medication Products for Cattle by Geographic Region/Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
Table 23: World Recent Past, Current and Future Analysis of Animal Medication Products for Pigs by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 24: World Historic Review of Animal Medication Products for Pigs by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 25: World 14-Year Perspective of Animal Medication Products for Pigs by Geographic Region/Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
Table 26: World Recent Past, Current and Future Analysis of Animal Medication Products for Other Farm Animals by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 27: World Historic Review of Animal Medication Products for Other Farm Animals by Geographic Region/Country – US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 28: World 14-Year Perspective of Animal Medication Products for Other Farm Animals by Geographic Region/Country – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
Table 29: World Recent Past, Current and Future Analysis for Animal Medication Products by Product Group – Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 30: World Historic Review for Animal Medication Products by Product Group – Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 31: World 14-Year Perspective for Animal Medication Products by Product Group – Percentage Breakdown of Dollar Sales for Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives and Others Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)

III. MARKET
1. THE UNITED STATES
A. Market Analysis
Current & Future Analysis
Food Safety Concerns and Biotechnological Offerings Drive the Veterinary Vaccines Market
Spending on Pets Rises to New Highs, Medications Drive Growth
Table 32: US Expenditure on Pets (2001-2015): Annual Expenditure in US$ Billion (includes corresponding Graph/Chart)
Table 33: US Pet Health Market (2015): Percentage Breakdown of Annual Consumer Spending on Pet Health by Type - Food, Live Animal Purchases, Pet Services (Grooming & Boarding), Supplies/OTC Medicine and Vet Care (includes corresponding Graph/Chart)
New Channels Emerge Challenging Veterinary Services’ Dominance
Table 34: US Pet Medications Market by Distribution Channel (2015): Percentage Breakdown of Sales for Veterinarians, Brick and Mortar Stores and Others (includes corresponding Graph/Chart)
Prescription Portability Gains Attention as New Channels Become Popular
Pet Owners Stand to Gain in the Changing Drug Distribution Environment
Significant Hurdles Exist for Generic Pet Medications
Pet Insurance on the Rise
Insurance Companies Galvanize Accessibility of Veterinary Innovations
Arsenic-based Animal Medicines Exit US Market, Concerns Remain over Lack of Alternatives
H5N1 Virus: A Conundrum for the US Animal Medication Industry
Regulations
Animal Drug Compounding and the Legalities Behind
FDA’s New Draft on Bulk Drug Compounding to Expand Treatment Options
Product Approvals/Launches
Strategic Corporate Developments
Key Players
B. Market Analytics
Table 35: The US Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 36: The US Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 37: The US 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
2. CANADA
A. Market Analysis
Current & Future Analysis
Overview of the Canadian Animal Health Industry
Imports and Manufacture of Veterinary Biologics
Product Launches
B. Market Analytics
Table 38: Canadian Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 39: Canadian Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 40: Canadian 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
3. JAPAN
Market Analysis
Table 41: Japanese Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 42: Japanese Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 43: Japanese 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
4. EUROPE
A. Market Analysis
Current & Future Analysis
Steady Growth Expected for Animal Vaccine Market Due to Superior Livestock Management
New Medicines Continue to Throng European Market
Table 44: EMA Veterinary Medicine Recommendations for Marketing Authorizations (2011-2015): Number of Drugs with Positive Opinions, Negative Opinions and Medicines withdrawn before Opinion (includes corresponding Graph/Chart)
New EMA Recommended Drugs for Marketing Authorization by Animal: 2015
Vaccines Make A Mark
A Peek into Nature and Indications of EMA- Recommended New Vaccines in 2015
Vaccine Regulations
EU Animal Welfare Strategy
New EU Regulations to Tighten Noose around Prolific Antibiotics Use in Animals
Mixed Reactions to Proposed New Law Emerge
EU Focuses on New Regulation for Veterinary Medicines Market
Key Statistical Findings
Table 45: European Pet Market (2014): Estimated Pet Population by Type of Pets - Cats, Dogs, Birds, Small Mammals and Aquaria (includes corresponding Graph/Chart)
Table 46: European Antimicrobials Market (2014): Percentage Share Breakdown of Dollar Sales of Antimicrobials by Type - Injectable Forms and Oral Forms (includes corresponding Graph/Chart)
Product Approvals/Launches
B. Market Analytics
Table 47: European Recent Past, Current and Future Analysis for Animal Medication Products by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 48: European Historic Review for Animal Medication Products by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 49: European 14-Year Perspective for Animal Medication Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
Table 50: European Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 51: European Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 52: European 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
4a. FRANCE
A. Market Analysis
Current & Future Analysis
France – A Leading Nation in Veterinary Medicine R&D
Table 53: French Animal Population (2013): Breakdown of Number of Animals by Type in Millions (includes corresponding Graph/Chart)
Product Launches
Strategic Corporate Developments
Key Players
B. Market Analytics
Table 54: French Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 55: French Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 56: French 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
4b. GERMANY
A. Market Analysis
Current & Future Analysis
Product Launches
Strategic Corporate Developments
Key Players
B. Market Analytics
Table 57: German Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 58: German Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 59: German 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
4c. ITALY
Market Analysis
Table 60: Italian Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 61: Italian Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 62: Italian 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A. Market Analysis
Current & Future Analysis
NOAH – The Regulatory Body behind Animal Medication in the UK
Key Statistics
Table 63: UK Pet Market (2016): Estimated Pet Population (In Million) by Type of Pets - Cats, Dogs, Indoor Fish, Outdoor Fish and Other Pets (includes corresponding Graph/Chart)
Table 64: UK Pet Market (2016): Estimated Percentage of Households by Type of Pets (includes corresponding Graph/Chart)
Table 65: UK Animal Medication Market by Product Type (2014 & 2015): Percentage Breakdown of Value Sales for Antimicrobials, Anti-inflammatories, Ectoparasiticides, Endoparasiticides, Reproductive Conditions, Vaccines and Others (includes corresponding Graph/Chart)
Table 66: UK Animal Medication Market by End-Segment (2005, 2010 & 2015): Percentage Breakdown of Value Sales for Companion Animals, Food-Producing Animals and Others (includes corresponding Graph/Chart)
Table 67: UK Animal Medication Market by Category (2014 & 2015): Percentage Breakdown of Value Sales for POM-V, POM-VPS and Others (includes corresponding Graph/Chart)
Product Launches
Strategic Corporate Development
Dechra Pharmaceuticals Plc - A Key Player
B. Market Analytics
Table 68: The UK Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 69: The UK Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 70: The UK 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
4e. SPAIN
A. Market Analysis
Current & Future Analysis
Product Launch
B. Market Analytics
Table 71: Spanish Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 72: Spanish Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 73: Spanish 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
4f. RUSSIA
A. Market Analysis
Current & Future Analysis
Russia Mass-Produces Vaccines against Avian Flu
B. Market Analytics
Table 74: Russian Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 75: Russian Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 76: Russian 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
4g. REST OF EUROPE
A. Market Analysis
Current & Future Analysis
A Review of Regional Animal Vaccine Markets
The Netherlands
Denmark
Product Launch
Merck Animal Health (Netherlands) – A Key Player
B. Market Analytics
Table 77: Rest of Europe Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 78: Rest of Europe Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 79: Rest of Europe 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A. Market Analysis
Current & Future Analysis
Product Launch
B. Market Analytics
Table 80: Asia-Pacific Recent Past, Current and Future Analysis for Animal Medication Products by Geographic Region/Country - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 81: Asia-Pacific Historic Review for Animal Medication Products by Geographic Region/Country - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 82: Asia-Pacific 14-Year Perspective for Animal Medication Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
Table 83: Asia-Pacific Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 84: Asia-Pacific Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 85: Asia-Pacific 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
5a. CHINA
A. Market Analysis
Current & Future Analysis
Growing Pet Industry Holds Promise
Increased Livestock Output Lead to Higher Vaccine Demand
Threat of Avian Influenza Outbreaks Creates Market for Effective Vaccine
Demand for Higher-Quality Swine Fever Vaccine
Demand for Effective PRRS Vaccines by Foreign Manufacturers
Highly Consolidated Chinese Animal Vaccine Market
Product Launch
B. Market Analytics
Table 86: Chinese Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 87: Chinese Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 88: Chinese 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
5b. INDIA
A. Market Analysis
Current & Future Analysis
Animal Vaccination Market Scenario
Major Players
Strategic Corporate Developments
B. Market Analytics
Table 89: Indian Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 90: Indian Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 91: Indian 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
A. Market Analysis
Current & Future Analysis
Review of Select Markets
Australia
A Note on Australian Veterinary Therapeutics Market
Key Statistical Findings
Table 92: Australian Pet Market (2014): Percentage Breakdown of Pet Population by Type of Pets - Dogs, Cats, Fish, Birds and Other Pets (includes corresponding Graph/Chart)
Table 93: Australian Pet Healthcare Market (2014): Percentage Share Breakdown of Annual Consumer Expenditure on Pet Health by Service Type (includes corresponding Graph/Chart)
Table 94: Australian Pet Healthcare Market (2014): Percentage Share Breakdown of Annual Consumer Expenditure on Veterinary Services by Pet Type - Dogs, Cats and Other Pets (includes corresponding Graph/Chart)
Table 95: Australian Pet Healthcare Market (2014): Percentage Breakdown of Annual Sales of Veterinary Chemicals by Product Type - Parasiticides, Immunotherapy, Nutritional and Metabolism, Antibiotics and Others (includes corresponding Graph/Chart)
Taiwan
Taiwan’s Animal Healthcare Industry under Scan
Strategic Corporate Developments
B. Market Analytics
Table 96: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 97: Rest of Asia-Pacific Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 98: Rest of Asia-Pacific 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
6. LATIN AMERICA
A. Market Analysis
Current & Future Analysis
Product Launch
B. Market Analytics
Table 99: Latin American Recent Past, Current and Future Analysis for Animal Medication Products by Geographic Region/Country - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 100: Latin American Historic Review for Animal Medication Products by Geographic Region/Country - Brazil, Mexico and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 101: Latin American 14-Year Perspective for Animal Medication Products by Geographic Region/Country - Percentage Breakdown of Dollar Sales for Brazil, Mexico and Rest of Latin America Markets for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
Table 102: Latin American Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 103: Latin American Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 104: Latin American 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
6a. BRAZIL
A. Market Analysis
Current & Future Analysis
Strategic Corporate Development
B. Market Analytics
Table 105: Brazilian Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 106: Brazilian Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 107: Brazilian 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
6b. MEXICO
Market Analysis
Table 108: Mexican Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 109: Mexican Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 110: Mexican 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
6c. REST OF LATIN AMERICA
Market Analysis
Table 111: Rest of Latin American Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 112: Rest of Latin American Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 113: Rest of Latin American 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
7. REST OF WORLD
Market Analysis
Table 114: Rest of World Recent Past, Current and Future Analysis for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
Table 115: Rest of World Historic Review for Animal Medication Products by End-Use Segments - Companion Animals and Farm Animals (Cattle, Pigs and Others) Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
Table 116: Rest of World 14-Year Perspective for Animal Medication Products by End-Use Segments - Percentage Breakdown of Dollar Sales for Companion Animals and Farm Animals (Cattle, Pigs and Others) for Years 2009, 2016, and 2022 (includes corresponding Graph/Chart)
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 113 (including Divisions/Subsidiaries - 131)
The United States (54)
Canada (2)
Japan (1)
Europe (41)
- France (4)
- Germany (6)
- The United Kingdom (8)
- Italy (2)
- Spain (1)
- Rest of Europe (20)
Asia-Pacific (Excluding Japan) (29)
Latin America (1)
Middle-East (3)

★調査レポート[動物用薬剤(コンパニオンアニマル、寄生虫駆除剤、ワクチン、その他)の世界市場]販売に関する免責事項
★調査レポート[動物用薬剤(コンパニオンアニマル、寄生虫駆除剤、ワクチン、その他)の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆